Vanderbilt University School of Medicine

Savani, Bipin N , MD
Professor of Medicine

Lab Url: N/A

Phone Number: (615) 343-5374

Email Address:bipin.savani@vanderbilt.edu

Savani, Bipin's picture

Office Address   Mailing Address

Hematology and Stem Cell Transplantation Section, 1301 Medical Center Drive; 3927 TVC, Nashville, TN 37232, USA

Hematology and Stem Cell Transplantation Section 37232


Publications
Bodge, MN, Culos, KA, Haider, SN, Thompson, MS, Savani, BN. Preparative Regimen Dosing for Hematopoietic Stem Cell Transplantation in Patients with Chronic Hepatic Impairment: Analysis of the Literature and Recommendations. Biol Blood Marrow Transplant, , , 2014.

Bodge, MN, Reddy, S, Thompson, MS, Savani, BN. Preparative Regimen Dosing for Hematopoietic Stem Cell Transplantation in Patients with Chronic Kidney Disease: Analysis of the Literature and Recommendations. Biol Blood Marrow Transplant, , , 2014.

Booth, GS, Gehrie, EA, Savani, BN. Minor RBC Ab and allo-SCT. Bone Marrow Transplant, 49(3), 456-7, 2014.

Bubalo, J, Carpenter, PA, Majhail, N, Perales, MA, Marks, DI, Shaughnessy, P, Pidala, J, Leather, HL, Wingard, J, Savani, BN. Conditioning chemotherapy dose adjustment in obese patients: A review and position statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee. Biol Blood Marrow Transplant, , , 2014.

Goswami, M, Hensel, N, Smith, BD, Prince, GT, Qin, L, Levitsky, HI, Strickland, SA, Jagasia, M, Savani, BN, Fraser, JW, Sadrzadeh, H, Rajkhowa, T, Ito, S, Jain, NA, Battiwalla, M, Fathi, AT, Levis, MJ, Barrett, AJ, Hourigan, CS. Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues. Leukemia, , , 2014.

Gupta, V, Malone, AK, Hari, PN, Ahn, KW, Hu, ZH, Gale, RP, Ballen, KK, Hamadani, M, Olavarria, E, Gerds, AT, Waller, EK, Costa, LJ, Antin, JH, Kamble, RT, van Besien, KM, Savani, BN, Schouten, HC, Szer, J, Cahn, JY, de Lima, MJ, Wirk, B, Aljurf, MD, Popat, U, Bejanyan, N, Litzow, MR, Norkin, M, Lewis, ID, Hale, GA, Woolfrey, AE, Miller, AM, Ustun, C, Jagasia, MH, Lill, M, Maziarz, RT, Cortes, J, Kalaycio, ME, Saber, W. Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant, 20(1), 89-97, 2014.

Hamadani, M, Abu Kar, SM, Usmani, SZ, Savani, BN, Ayala, E, Kharfan-Dabaja, MA. Management of relapses after hematopoietic cell transplantation in T-cell non-hodgkin lymphomas. Semin Hematol, 51(1), 73-86, 2014.

Hu, B, Vikas, P, Mohty, M, Savani, BN. Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update. Expert Rev Hematol, 7(2), 301-15, 2014.

Jain, NA, Pophali, PA, Klotz, JK, Ito, S, Koklanaris, E, Chawla, K, Hourigan, CS, Gormley, N, Savani, BN, Barrett, AJ, Battiwalla, M. Repair of impaired pulmonary function is possible in very-long-term allogeneic stem cell transplantation survivors. Biol Blood Marrow Transplant, 20(2), 209-13, 2014.

Joshi, S, Savani, BN, Chow, EJ, Gilleece, MH, Halter, J, Jacobsohn, DA, Pidala, J, Quinn, GP, Cahn, JY, Jakubowski, AA, Kamani, NR, Lazarus, HM, Rizzo, JD, Schouten, HC, Socie, G, Stratton, P, Sorror, ML, Warwick, AB, Wingard, JR, Loren, AW, Majhail, NS. Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant, , , 2014.

Kharfan-Dabaja, MA, Hamadani, M, Sibai, H, Savani, BN. Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all. Bone Marrow Transplant, , , 2014.

Li, X, Brazauskas, R, Wang, Z, Al-Seraihy, A, Baker, KS, Cahn, JY, Frangoul, HA, Gajewski, JL, Hale, GA, Hsu, JW, Kamble, RT, Lazarus, HM, Marks, DI, Maziarz, RT, Savani, BN, Shah, AJ, Shah, N, Sorror, ML, Wood, WA, Majhail, NS. Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents. Biol Blood Marrow Transplant, 20(4), 587-92, 2014.

Mathews, V, Savani, BN. Conditioning regimens in allo-SCT for thalassemia major. Bone Marrow Transplant, , , 2014.

McClune, BL, Ahn, KW, Wang, HL, Antin, JH, Artz, AS, Cahn, JY, Deol, A, Freytes, CO, Hamadani, M, Holmberg, LA, Jagasia, MH, Jakubowski, AA, Kharfan-Dabaja, MA, Lazarus, HM, Miller, AM, Olsson, R, Pedersen, TL, Pidala, J, Pulsipher, MA, Rowe, JM, Saber, W, van Besien, KW, Waller, EK, Aljurf, MD, Akpek, G, Bacher, U, Chao, NJ, Chen, YB, Cooper, BW, Dehn, J, de Lima, MJ, Hsu, JW, Lewis, ID, Marks, DI, McGuirk, J, Cairo, MS, Schouten, HC, Szer, J, Ramanathan, M, Savani, BN, Seftel, M, Socie, G, Vij, R, Warlick, ED, Weisdorf, DJ. Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival. Biol Blood Marrow Transplant, , , 2014.

Mohty, M, Malard, F, Mohty, B, Savani, B, Moreau, P, Terpos, E. The effects of bortezomib on bone disease in patients with multiple myeloma. Cancer, 120(5), 618-23, 2014.

Pophali, PA, Klotz, JK, Ito, S, Jain, NA, Koklanaris, E, Le, RQ, Hourigan, CS, Savani, BN, Chawla, K, Shanbhag, S, Barrett, AJ, Battiwalla, M. Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events. Exp Hematol, 42(2), 83-9, 2014.

Ragon, BK, Clifton, C, Chen, H, Savani, BN, Engelhardt, BG, Kassim, AA, Vaughan, LA, Lucid, C, Jagasia, M. Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy. Biol Blood Marrow Transplant, 20(1), 53-7, 2014.

Reddy, NM, Oluwole, O, Greer, JP, Engelhardt, BG, Jagasia, MH, Savani, BN. Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma. Exp Hematol, 42(1), 39-45, 2014.

Reddy, NM, Savani, BN. Management of T-cell lymphomas: overcoming challenges and choosing the best treatment. Semin Hematol, 51(1), 1-4, 2014.

Saad, A, Mahindra, A, Zhang, MJ, Zhong, X, Costa, LJ, Dispenzieri, A, Drobyski, WR, Freytes, CO, Gale, RP, Gasparetto, CJ, Holmberg, LA, Kamble, RT, Krishnan, AY, Kyle, RA, Marks, D, Nishihori, T, Pasquini, MC, Ramanathan, M, Lonial, S, Savani, BN, Saber, W, Sharma, M, Sorror, ML, Wirk, BM, Hari, PN. Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. Biol Blood Marrow Transplant, 20(3), 402-408.e1, 2014.

Sengsayadeth, S, Savani, BN. Age is more than a number. Cytotherapy, 16(3), 287-8, 2014.

Sengsayadeth, S, Wang, T, Lee, SJ, Haagenson, MD, Spellman, S, Fernandez Vi??a, MA, Muller, CR, Verneris, MR, Savani, BN, Jagasia, M. Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Single Nucleotide Polymorphisms Are Not Associated with Outcomes after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis. Biol Blood Marrow Transplant, , , 2014.

Warlick, ED, Paulson, K, Brazauskas, R, Zhong, X, Miller, AM, Camitta, BM, George, B, Savani, BN, Ustun, C, Marks, DI, Waller, EK, Baron, F, Freytes, CO, Socie, G, Akpek, G, Schouten, HC, Lazarus, HM, Horwitz, EM, Koreth, J, Cahn, JY, Bornhauser, M, Seftel, M, Cairo, MS, Laughlin, MJ, Sabloff, M, Ringd??n, O, Gale, RP, Kamble, RT, Vij, R, Gergis, U, Mathews, V, Saber, W, Chen, YB, Liesveld, JL, Cutler, CS, Ghobadi, A, Uy, GL, Eapen, M, Weisdorf, DJ, Litzow, MR. Effect of Postremission Therapy before Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia in First Complete Remission. Biol Blood Marrow Transplant, 20(2), 202-8, 2014.

Wirk, B, Fenske, TS, Hamadani, M, Zhang, MJ, Hu, ZH, Akpek, G, Aljurf, MD, Armand, P, Ayala, E, Bachanova, V, Bolwell, B, Cairo, MS, Cashen, A, Chen, YB, Costa, LJ, Farhan, S, Freytes, CO, Gajewski, JL, Gibson, J, Hale, GA, Holmberg, LA, Hsu, JW, Inwards, DJ, Kamble, RT, Maharaj, D, Maziarz, RT, Munker, R, Nath, R, Reddy, NM, Reeder, CB, Rizzieri, DA, Sauter, CS, Savani, BN, Schouten, HC, Sureda, A, Vose, JM, Waller, EK, Wiernik, PH, Gale, RP, Burns, LJ, Saber, W. Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Biol Blood Marrow Transplant, , , 2014.

Bachanova, V, Marks, DI, Zhang, MJ, Wang, H, de Lima, M, Aljurf, MD, Arellano, M, Artz, AS, Bacher, U, Cahn, JY, Chen, YB, Copelan, EA, Drobyski, WR, Gale, RP, Greer, JP, Gupta, V, Hale, GA, Kebriaei, P, Lazarus, HM, Lewis, ID, Lewis, VA, Liesveld, JL, Litzow, MR, Loren, AW, Miller, AM, Norkin, M, Oran, B, Pidala, J, Rowe, JM, Savani, BN, Saber, W, Vij, R, Waller, EK, Wiernik, PH, Weisdorf, DJ. Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease. Leukemia, , , 2013.

Booth, GS, Gehrie, EA, Bolan, CD, Savani, BN. Clinical Guide to ABO-Incompatible Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant, 19(8), 1152-8, 2013.

Booth, GS, Gehrie, EA, Savani, BN. Response to "What Is the Optimal Approach to Major ABO-Incompatible Allogeneic Stem Cell Transplantation". Biol Blood Marrow Transplant, 19(12), 1760-1, 2013.

Copelan, EA, Hamilton, BK, Avalos, B, Ahn, KW, Bolwell, BJ, Zhu, X, Aljurf, M, van Besien, K, Bredeson, C, Cahn, JY, Costa, LJ, de Lima, M, Gale, RP, Hale, GA, Halter, J, Hamadani, M, Inamoto, Y, Kamble, RT, Litzow, MR, Loren, AW, Marks, DI, Olavarria, E, Roy, V, Sabloff, M, Savani, BN, Seftel, M, Schouten, HC, Ustun, C, Waller, EK, Weisdorf, DJ, Wirk, B, Horowitz, MM, Arora, M, Szer, J, Cortes, J, Kalaycio, ME, Maziarz, RT, Saber, W. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood, 122(24), 3863-70, 2013.

Costa, LJ, Zhang, MJ, Zhong, X, Dispenzieri, A, Lonial, S, Krishnan, A, Freytes, C, Vesole, D, Gale, RP, Anderson, K, Wirk, B, Savani, BN, Waller, EK, Schouten, H, Lazarus, H, Meehan, K, Sharma, M, Kamble, R, Vij, R, Kumar, S, Nishihori, T, Kindwall-Keller, T, Saber, W, Hari, PN. Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. Biol Blood Marrow Transplant, 19(11), 1615-24, 2013.

Danner-Koptik, KE, Majhail, NS, Brazauskas, R, Wang, Z, Buchbinder, D, Cahn, JY, Dilley, KJ, Frangoul, HA, Gross, TG, Hale, GA, Hayashi, RJ, Hijiya, N, Kamble, RT, Lazarus, HM, Marks, DI, Reddy, V, Savani, BN, Warwick, AB, Wingard, JR, Wood, WA, Sorror, ML, Jacobsohn, DA. Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant, 48(3), 363-8, 2013.

Foran, JM, Pavletic, SZ, Logan, BR, Agovi-Johnson, MA, P??rez, WS, Bolwell, BJ, Bornh??user, M, Bredeson, CN, Cairo, MS, Camitta, BM, Copelan, EA, Dehn, J, Gale, RP, George, B, Gupta, V, Hale, GA, Lazarus, HM, Litzow, MR, Maharaj, D, Marks, DI, Martino, R, Maziarz, RT, Rowe, JM, Rowlings, PA, Savani, BN, Savoie, ML, Szer, J, Waller, EK, Wiernik, PH, Weisdorf, DJ. Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. Biol Blood Marrow Transplant, 19(7), 1102-8, 2013.

Hamadani, M, Saber, W, Ahn, KW, Carreras, J, Cairo, MS, Fenske, TS, Gale, RP, Gibson, J, Hale, GA, Hari, PN, Hsu, JW, Inwards, DJ, Kamble, RT, Klein, A, Maharaj, D, Marks, DI, Rizzieri, DA, Savani, BN, Schouten, HC, Waller, EK, Wirk, B, Laport, GG, Montoto, S, Maloney, DG, Lazarus, HM. Impact of Pretransplantation Conditioning Regimens on??Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III Follicular Lymphoma. Biol Blood Marrow Transplant, 19(5), 746-53, 2013.

Hamadani, M, Saber, W, Ahn, KW, Carreras, J, Cairo, MS, Fenske, TS, Gale, RP, Gibson, J, Hale, GA, Hari, PN, Hsu, JW, Inwards, DJ, Kamble, RT, Klein, A, Maharaj, D, Marks, DI, Rizzieri, DA, Savani, BN, Schouten, HC, Waller, EK, Wirk, B, Lazarus, HM. Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant, 19(4), 625-31, 2013.

Jagasia, M, Greinix, H, Robin, M, Das-Gupta, E, Jacobs, R, Savani, BN, Engelhardt, BG, Kassim, A, Worel, N, Knobler, R, Russell, N, Socie, G. Extracorporeal Photopheresis versus Anticytokine Therapy as a Second-Line Treatment for Steroid-Refractory Acute GVHD: A Multicenter Comparative Analysis. Biol Blood Marrow Transplant, 19(7), 1129-33, 2013.

Lee, SJ, Storer, B, Wang, H, Lazarus, HM, Waller, EK, Isola, LM, Klumpp, TR, Umejiego, JB, Savani, BN, Loren, AW, Cairo, MS, Camitta, BM, Cutler, CS, George, B, Jean Khoury, H, Marks, DI, Rizzieri, DA, Copelan, EA, Gupta, V, Liesveld, JL, Litzow, MR, Miller, AM, Schouten, HC, Gale, RP, Cahn, JY, Weisdorf, DJ. Providing personalized prognostic information for adult leukemia survivors. Biol Blood Marrow Transplant, 19(11), 1600-7, 2013.

Logue, M, Savani, BN. Understanding basic steps to hematopoietic stem cell transplantation evaluation. Am J Blood Res, 3(2), 102-6, 2013.

Michaelis, LC, Saad, A, Zhong, X, Le-Rademacher, J, Freytes, CO, Marks, DI, Lazarus, HM, Bird, JM, Holmberg, L, Kamble, RT, Kumar, S, Lill, M, Meehan, KR, Saber, W, Schriber, J, Tay, J, Vogl, DT, Wirk, B, Savani, BN, Gale, RP, Vesole, DH, Schiller, GJ, Abidi, M, Anderson, KC, Nishihori, T, Kalaycio, ME, Vose, JM, Moreb, JS, Drobyski, W, Munker, R, Roy, V, Ghobadi, A, Holland, HK, Nath, R, To, LB, Maiolino, A, Kassim, AA, Giralt, SA, Landau, H, Schouten, HC, Maziarz, RT, Michael, J, Kindwall-Keller, T, Stiff, PJ, Gibson, J, Lonial, S, Krishnan, A, Dispenzieri, A, Hari, P, , . Salvage Second Hematopoietic Cell Transplantation in??Myeloma. Biol Blood Marrow Transplant, 19(5), 760-6, 2013.

Mohty, M, Brissot, E, Savani, BN, Gaugler, B. Effects of bortezomib on the immune system: a focus on immune regulation. Biol Blood Marrow Transplant, 19(10), 1416-20, 2013.

Savani, BN. Ferritin and FerriScan in HCT recipients. Blood, 122(9), 1539-41, 2013.

Sengsayadeth, SM, Savani, BN. Umbilical cord blood transplant: expanding the options. Expert Rev Hematol, 6(4), 341-2, 2013.

Vaughan, LA, Vu, M, Sengsayadeth, S, Lucid, C, Clifton, C, McCarty, K, Hagaman, D, Domm, J, Kassim, A, Chinratanalab, W, Goodman, S, Greer, J, Frangoul, H, Engelhardt, BG, Jagasia, M, Savani, BN. New allergies after cord blood transplantation. Cytotherapy, 15(10), 1259-65, 2013.

Wulff-Burchfield, EM, Jagasia, M, Savani, BN. Long-term follow-up of informal caregivers after allo-SCT: a systematic review. Bone Marrow Transplant, 48(4), 469-73, 2013.

Wulff-Burchfield, EM, Savani, BN. Building a Transplantation Physician Workforce for Growing Need: Recruitment Starts during Residency. Biol Blood Marrow Transplant, 19(8), 1142-3, 2013.

Armand, P, Kim, HT, Zhang, MJ, Perez, WS, Dal Cin, PS, Klumpp, TR, Waller, EK, Litzow, MR, Liesveld, JL, Lazarus, HM, Artz, AS, Gupta, V, Savani, BN, McCarthy, PL, Cahn, JY, Schouten, HC, Finke, J, Ball, ED, Aljurf, MD, Cutler, CS, Rowe, JM, Antin, JH, Isola, LM, Di Bartolomeo, P, Camitta, BM, Miller, AM, Cairo, MS, Stockerl-Goldstein, K, Sierra, J, Savoie, ML, Halter, J, Stiff, PJ, Nabhan, C, Jakubowski, AA, Bunjes, DW, Petersdorf, EW, Devine, SM, Maziarz, RT, Bornhauser, M, Lewis, VA, Marks, DI, Bredeson, CN, Soiffer, RJ, Weisdorf, DJ. Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biol Blood Marrow Transplant, 18(2), 280-8, 2012.

Ballen, KK, Woolfrey, AE, Zhu, X, Ahn, KW, Wirk, B, Arora, M, George, B, Savani, BN, Bolwell, B, Porter, DL, Copelan, E, Hale, G, Schouten, HC, Lewis, I, Cahn, JY, Halter, J, Cortes, J, Kalaycio, ME, Antin, J, Aljurf, MD, Carabasi, MH, Hamadani, M, McCarthy, P, Pavletic, S, Gupta, V, Deeg, HJ, Maziarz, RT, Horowitz, MM, Saber, W. Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. Biol Blood Marrow Transplant, 18(9), 1446-54, 2012.

Battiwalla, M, Ellis, K, Li, P, Pavletic, SZ, Akpek, G, Hematti, P, Klumpp, TR, Maziarz, RT, Savani, BN, Aljurf, MD, Cairo, MS, Drobyski, WR, George, B, Hahn, T, Khera, N, Litzow, MR, Loren, AW, Saber, W, Arora, M, Urbano-Ispizua, A, Cutler, C, Flowers, ME, Spellman, SR. HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies. Biol Blood Marrow Transplant, 18(8), 1302-8, 2012.

Benrashid, M, Moyers, K, Mohty, M, Savani, BN. Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: Implication for preventive therapy. Exp Hematol, 40(4), 263-7, 2012.

Brissot, E, Savani, BN, Mohty, M. Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation. Semin Hematol, 49(1), 35-42, 2012.

Buchbinder, D, Nugent, DJ, Brazauskas, R, Wang, Z, Aljurf, MD, Cairo, MS, Chow, R, Duncan, C, Eldjerou, LK, Gupta, V, Hale, GA, Halter, J, Hayes-Lattin, BM, Hsu, JW, Jacobsohn, DA, Kamble, RT, Kasow, KA, Lazarus, HM, Mehta, P, Myers, KC, Parsons, SK, Passweg, JR, Pidala, J, Reddy, V, Sales-Bonfim, CM, Savani, BN, Seber, A, Sorror, ML, Steinberg, A, Wood, WA, Wall, DA, Winiarski, JH, Yu, LC, Majhail, NS. Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research. Biol Blood Marrow Transplant, 18(12), 1776-84, 2012.

Chinratanalab, W, Reddy, N, Greer, JP, Morgan, D, Engelhardt, B, Kassim, A, Brandt, SJ, Jagasia, M, Goodman, S, Savani, BN. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Exp Hematol, 40(6), 431-5, 2012.

Dunn, D, Vikas, P, Jagasia, M, Savani, BN. Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease. Bone Marrow Transplant, 47(8), 1136-7, 2012.

Engelhardt, BG, Jagasia, SM, Crowe, JE, Griffith, ML, Savani, BN, Kassim, AA, Lu, P, Weitkamp, JH, Moore, DJ, Yoder, SM, Rock, MT, Jagasia, M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood, 119(10), 2417-21, 2012.

Engelhardt, BG, Sengsayadeth, SM, Jagasia, M, Savani, BN, Kassim, AA, Lu, P, Shyr, Y, Yoder, SM, Rock, MT, Crowe, JE. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp Hematol, 40(12), 974-982.e1, 2012.

Hart, AJ, Jagasia, MH, Kim, AS, Mosse, CA, Savani, BN, Kassim, A. Minimal residual disease in myeloma: are we there yet. Biol Blood Marrow Transplant, 18(12), 1790-9, 2012.

Jacobs, R, Tran, U, Chen, H, Kassim, A, Engelhardt, BG, Greer, JP, Goodman, SG, Clifton, C, Lucid, C, Vaughan, LA, Savani, BN, Jagasia, M. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant, 47(11), 1470-3, 2012.

Jagasia, M, Clark, WB, Brown-Gentry, KD, Crawford, DC, Fan, KH, Chen, H, Kassim, A, Greer, JP, Engelhardt, BG, Savani, BN. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant, 18(7), 1069-75, 2012.

Johnson, DB, Savani, BN. How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation. Exp Hematol, 40(7), 513-7, 2012.

Martin, PJ, Rizzo, JD, Wingard, JR, Ballen, K, Curtin, PT, Cutler, C, Litzow, MR, Nieto, Y, Savani, BN, Schriber, JR, Shaughnessy, PJ, Wall, DA, Carpenter, PA. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant, 18(8), 1150-63, 2012.

Reddy, N, Greer, JP, Goodman, S, Engelhardt, B, Oluwole, O, Jagasia, MH, Savani, BN. Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma. Bone Marrow Transplant, 47(10), 1318-20, 2012.

Reddy, N, Greer, JP, Goodman, S, Kassim, A, Morgan, DS, Chinratanalab, W, Brandt, S, Englehardt, B, Oluwole, O, Jagasia, MH, Savani, BN. Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Exp Hematol, 40(5), 359-66, 2012.

Reddy, N, Oluwole, O, Greer, JP, Goodman, S, Engelhardt, B, Jagasia, MH, Savani, BN. Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation. Clin Lymphoma Myeloma Leuk, 12(6), 406-11, 2012.

Reddy, N, Savani, BN. Primary central nervous system lymphoma: implication of high-dose chemotherapy followed by auto-SCT. Bone Marrow Transplant, 47(10), 1265-8, 2012.

Rezvani, K, Yong, AS, Mielke, S, Savani, BN, Jafarpour, B, Eniafe, R, Le, RQ, Musse, L, Boss, C, Childs, R, John Barrett, A. Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy. Cancer Immunol Immunother, 61(7), 1125-36, 2012.

Savani, BN. How can we improve life expectancy and quality of life in long-term survivors after allogeneic stem cell transplantation. Semin Hematol, 49(1), 1-3, 2012.

Sengsayadeth, SM, Jagasia, M, Engelhardt, BG, Kassim, A, Strickland, SA, Goodman, S, Lucid, C, Vnencak-Jones, CL, Greer, JP, Savani, BN. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant, 47(12), 1535-7, 2012.

Sengsayadeth, SM, Srivastava, S, Jagasia, M, Savani, BN. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 18(10), 1479-87, 2012.

Shanis, D, Merideth, M, Pulanic, TK, Savani, BN, Battiwalla, M, Stratton, P. Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management. Semin Hematol, 49(1), 83-93, 2012.

Stover, DG, Reddy, VK, Shyr, Y, Savani, BN, Reddy, N. Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma. Bone Marrow Transplant, 47(1), 82-7, 2012. PMCID:3109546

Warlick, E, Ahn, KW, Pedersen, TL, Artz, A, de Lima, M, Pulsipher, M, Akpek, G, Aljurf, M, Cahn, JY, Cairo, M, Chen, YB, Cooper, B, Deol, A, Giralt, S, Gupta, V, Khoury, HJ, Kohrt, H, Lazarus, HM, Lewis, I, Olsson, R, Pidala, J, Savani, BN, Seftel, M, Soci??, G, Tallman, M, Ustun, C, Vij, R, Vindel??v, L, Weisdorf, D. Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. Blood, 119(17), 4083-90, 2012.

Zatarain, L, Savani, BN. The role of nutrition and effects on the cytokine milieu in allogeneic hematopoietic stem cell transplantation. Cell Immunol, 276(1-2), 6-9, 2012.

Clark, WB, Brown-Gentry, KD, Crawford, DC, Fan, KH, Snavely, J, Chen, H, Savani, BN, Kassim, A, Greer, JP, Schuening, FG, Engelhardt, BG, Jagasia, MH. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD. Blood, 118(4), 1140-4, 2011.

Engelhardt, BG, Jagasia, M, Savani, BN, Bratcher, NL, Greer, JP, Jiang, A, Kassim, AA, Lu, P, Schuening, F, Yoder, SM, Rock, MT, Crowe, JE. Regulatory T cell expression of CLA or I?(4)I?(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant, 46(3), 436-42, 2011. PMCID:3217583

Griffith, ML, Jagasia, MH, Misfeldt, AA, Chen, H, Engelhardt, BG, Kassim, A, Savani, BN, Survant, M, Jagasia, SM. Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 17(1), 86-92, 2011. PMCID:3217583

Jagasia, MH, Savani, BN, Neff, A, Dixon, S, Chen, H, Pickard, AS. Outcome, toxicity profile and cost analysis of autologous stem cell mobilization. Bone Marrow Transplant, 46(8), 1084-8, 2011. PMCID:3046275

Le, RQ, Melenhorst, JJ, Battiwalla, M, Hill, B, Memon, S, Savani, BN, Shenoy, A, Hensel, NF, Koklanaris, EK, Keyvanfar, K, Hakim, FT, Douek, DC, Barrett, AJ. Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation. Blood, 117(19), 5250-6, 2011. PMCID:3109546

Loren, AW, Chow, E, Jacobsohn, DA, Gilleece, M, Halter, J, Joshi, S, Wang, Z, Sobocinski, KA, Gupta, V, Hale, GA, Marks, DI, Stadtmauer, EA, Apperley, J, Cahn, JY, Schouten, HC, Lazarus, HM, Savani, BN, McCarthy, PL, Jakubowski, AA, Kamani, NR, Hayes-Lattin, B, Maziarz, RT, Warwick, AB, Sorror, ML, Bolwell, BJ, Soci??, G, Wingard, JR, Rizzo, JD, Majhail, NS. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant, 17(2), 157-66, 2011. PMCID:3017731

Lucid, CE, Savani, BN, Engelhardt, BG, Shah, P, Clifton, C, Greenhut, SL, Vaughan, LA, Kassim, A, Schuening, F, Jagasia, M. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant, 46(3), 426-9, 2011. PMCID:3017731

Mielke, S, McIver, ZA, Shenoy, A, Fellowes, V, Khuu, H, Stroncek, DF, Leitman, SF, Childs, R, Battiwalla, M, Koklanaris, E, Haggerty, J, Savani, BN, Rezvani, K, Barrett, AJ. Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies. Biol Blood Marrow Transplant, 17(12), 1855-61, 2011.

Reddy, N, Rezvani, K, Barrett, AJ, Savani, BN. Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients. Biol Blood Marrow Transplant, 17(5), 591-7, 2011. PMCID:3046275

Reddy, N, Savani, BN. Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach. Biol Blood Marrow Transplant, 17(9), 1265-72, 2011. PMCID:3156833

Rezvani, K, Yong, AS, Mielke, S, Jafarpour, B, Savani, BN, Le, RQ, Eniafe, R, Musse, L, Boss, C, Kurlander, R, Barrett, AJ. Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies. Haematologica, 96(3), 432-40, 2011. PMCID:3046275

Savani, BN. Can we modify transplant outcome by improving lymphocyte recovery. Cytotherapy, 13(8), 900-2, 2011.

Savani, BN, Griffith, ML, Jagasia, S, Lee, SJ. How I treat late effects in adults after allogeneic stem cell transplantation. Blood, 117(11), 3002-9, 2011. PMCID:3062306

Tedeschi, SK, Jagasia, M, Engelhardt, BG, Domm, J, Kassim, AA, Chinratanalab, W, Greenhut, SL, Goodman, S, Greer, JP, Schuening, F, Frangoul, H, Savani, BN. Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Cytotherapy, 13(1), 78-82, 2011. PMCID:3017731

Tedesco, J, Qualtieri, J, Head, D, Savani, BN, Reddy, N. High Prevalence of Obesity in Acute Promyelocytic Leukemia (APL): Implications for Differentiating Agents in APL and Metabolic Syndrome. Ther Adv Hematol, 2(3), 141-5, 2011.

Yong, AS, Stephens, N, Weber, G, Li, Y, Savani, BN, Eniafe, R, Keyvanfar, K, Kurlander, R, Rezvani, K, Barrett, AJ. Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein. Leukemia, 25(4), 629-37, 2011. PMCID:3076540

Clark, WB, Strickland, SA, Barrett, AJ, Savani, BN. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Haematologica, 95(6), 860-3, 2010. PMCID:2878780

Griffith, ML, Savani, BN, Boord, JB. Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management. Blood, 116(8), 1197-204, 2010. PMCID:2878780

Le, RQ, Bevans, M, Savani, BN, Mitchell, SA, Stringaris, K, Koklanaris, E, Barrett, AJ. Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant, 16(8), 1162-70, 2010. PMCID:2897903

Savani, BN. Transplantation in AML CR1. Blood, 116(11), 1822-3, 2010. PMCID:3046275

Stringaris, K, Adams, S, Uribe, M, Eniafe, R, Wu, CO, Savani, BN, Barrett, AJ. Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies. Biol Blood Marrow Transplant, 16(9), 1257-64, 2010. PMCID:2897903

Tedeschi, SK, Savani, BN, Jagasia, M, Engelhardt, B, Anasetti, C, Barrett, AJ, Lee, S. Time to consider HPV vaccination after allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 16(8), 1033-6, 2010. PMCID:2878780

Venepalli, N, Rezvani, K, Mielke, S, Savani, BN. Role of allo-SCT for CML in 2010. Bone Marrow Transplant, 45(11), 1579-86, 2010. PMCID:3217583

Barrett, AJ, Savani, BN. Does chemotherapy modify the immune surveillance of hematological malignancies. Leukemia, 23(1), 53-8, 2009. PMCID:2630272

Jagasia, MH, Savani, BN, Stricklin, G, Engelhardt, B, Kassim, A, Dixon, S, Chen, H, Chinratanalab, W, Goodman, S, Greer, JP, Schuening, F. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol Blood Marrow Transplant, 15(10), 1288-95, 2009. PMCID:3159406

Le, Q, Shenoy, A, Koklanaris, E, Childs, R, John Barrett, A, Savani, BN. Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 15(7), 886-7, 2009. PMCID:3159406

Reddy, N, Goodman, S, Savani, BN. Prophylactic intravenous immunoglobulin does not have a role in hematopoietic stem-cell transplantation: is the evidence clear. J Clin Oncol, 27(13), 2296-7; author reply 2297-8, 2009. PMCID:3159406

Rezvani, K, Yong, AS, Tawab, A, Jafarpour, B, Eniafe, R, Mielke, S, Savani, BN, Keyvanfar, K, Li, Y, Kurlander, R, Barrett, AJ. Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia. Blood, 113(10), 2245-55, 2009. PMCID:2652370

Savani, BN, Goodman, S, Barrett, AJ. Can routine posttransplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation. Clin Cancer Res, 15(7), 2219-21, 2009. PMCID:3159406

Savani, BN, Goodman, S, Reddy, N. Does extra alemtuzumab remove the graft-versus-leukemia effect after allogeneic stem cell transplantation in chronic lymphocytic leukemia. Biol Blood Marrow Transplant, 15(4), 517-8, 2009. PMCID:3159406

Savani, BN, Koklanaris, EK, Le, Q, Shenoy, A, Goodman, S, Barrett, AJ. Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant, 15(3), 377-81, 2009. PMCID:3159406

Savani, BN, Mielke, S, Reddy, N, Goodman, S, Jagasia, M, Rezvani, K. Management of relapse after allo-SCT for AML and the role of second transplantation. Bone Marrow Transplant, 44(12), 769-77, 2009. PMCID:2897903

Savani, BN, Pohlmann, PR, Jagasia, M, Chinratanalab, W, Kassim, A, Engelhardt, B, Greer, J, Schuening, F, Goodman, S. Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD. Blood, 113(24), 6263-4, 2009. PMCID:3159406

Yong, AS, Keyvanfar, K, Hensel, N, Eniafe, R, Savani, BN, Berg, M, Lundqvist, A, Adams, S, Sloand, EM, Goldman, JM, Childs, R, Barrett, AJ. Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib. Blood, 113(4), 875-82, 2009. PMCID:2630272

Barrett, AJ, Savani, BN. Allogeneic stem cell transplantation for myelodysplastic syndrome. Semin Hematol, 45(1), 49-59, 2008. PMCID:2574650

Melenhorst, JJ, Scheinberg, P, Lu, J, Ambrozak, DR, Sosa, E, Zhao, L, Hensel, NF, Savani, BN, Douek, DC, Price, DA, Barrett, AJ. Regulatory T-cell depletion does not prevent emergence of new CD25+ FOXP3+ lymphocytes after antigen stimulation in culture. Cytotherapy, 10(2), 152-64, 2008. PMCID:2574650

Rezvani, K, Yong, AS, Mielke, S, Savani, BN, Musse, L, Superata, J, Jafarpour, B, Boss, C, Barrett, AJ. Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies. Blood, 111(1), 236-42, 2008. PMCID:2200809

Savani, BN, Stratton, P, Shenoy, A, Kozanas, E, Goodman, S, Barrett, AJ. Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination. Biol Blood Marrow Transplant, 14(9), 1072-5, 2008. PMCID:2946417

Savani, K, Markus, HR, Conner, AL. Let your preference be your guide? Preferences and choices are more tightly linked for North Americans than for Indians. J Pers Soc Psychol, 95(4), 861-76, 2008. PMCID:3109546

Schubert, J, Hillmen, P, R??th, A, Young, NS, Elebute, MO, Szer, J, Gianfaldoni, G, Soci??, G, Browne, P, Geller, R, Rother, RP, Muus, P, , . Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol, 142(2), 263-72, 2008. PMCID:2574650

Yong, AS, Keyvanfar, K, Eniafe, R, Savani, BN, Rezvani, K, Sloand, EM, Goldman, JM, Barrett, AJ. Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy. Leukemia, 22(9), 1721-7, 2008. PMCID:2574650

Mielke, S, Rezvani, K, Savani, BN, Nunes, R, Yong, AS, Schindler, J, Kurlander, R, Ghetie, V, Read, EJ, Solomon, SR, Vitetta, ES, Barrett, AJ. Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood, 110(5), 1689-97, 2007. PMCID:1975850

Rezvani, K, Yong, AS, Savani, BN, Mielke, S, Keyvanfar, K, Gostick, E, Price, DA, Douek, DC, Barrett, AJ. Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia. Blood, 110(6), 1924-32, 2007. PMCID:1976363

Savani, BN, Donohue, T, Kozanas, E, Shenoy, A, Singh, AK, Childs, RW, Barrett, AJ. Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 13(5), 517-20, 2007. PMCID:1975850

Savani, BN, Mielke, S, Adams, S, Uribe, M, Rezvani, K, Yong, AS, Zeilah, J, Kurlander, R, Srinivasan, R, Childs, R, Hensel, N, Barrett, AJ. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia, 21(10), 2145-52, 2007. PMCID:2630272

Savani, BN, Mielke, S, Rezvani, K, Montero, A, Yong, AS, Wish, L, Superata, J, Kurlander, R, Singh, A, Childs, R, Barrett, AJ. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 13(10), 1216-23, 2007. PMCID:3426353

Shenoy, A, Savani, BN, Barrett, AJ. Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 13(5), 622-3, 2007. PMCID:2200809

Singh, AK, Savani, BN, Albert, PS, Barrett, AJ. Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation. Biol Blood Marrow Transplant, 13(3), 339-44, 2007. PMCID:1924474

Soule, BP, Simone, NL, Savani, BN, Ning, H, Albert, PS, Barrett, AJ, Singh, AK. Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant, 40(6), 573-8, 2007. PMCID:2200809

Yong, AS, Rezvani, K, Savani, BN, Eniafe, R, Mielke, S, Goldman, JM, Barrett, AJ. High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects. Blood, 110(2), 770-5, 2007. PMCID:1924474

Barrett, AJ, Savani, BN. Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents. Leukemia, 20(10), 1661-72, 2006. PMCID:1849949

Montero, A, Savani, BN, Shenoy, A, Read, EJ, Carter, CS, Leitman, SF, Mielke, S, Rezvani, K, Childs, R, Barrett, AJ. T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome. Biol Blood Marrow Transplant, 12(12), 1318-25, 2006. PMCID:1924474

Rezvani, K, Mielke, S, Ahmadzadeh, M, Kilical, Y, Savani, BN, Zeilah, J, Keyvanfar, K, Montero, A, Hensel, N, Kurlander, R, Barrett, AJ. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood, 108(4), 1291-7, 2006. PMCID:1895877

Savani, BN, Dunbar, CE, Rick, ME. Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization. Am J Hematol, 81(3), 218-9, 2006. PMCID:2200809

Savani, BN, Kozanas, E, Shenoy, A, Barrett, AJ. Recovery of spermatogenesis after total-body irradiation. Blood, 108(13), 4292-3; author reply 4293-4, 2006. PMCID:1849949

Savani, BN, Montero, A, Srinivasan, R, Singh, A, Shenoy, A, Mielke, S, Rezvani, K, Karimpour, S, Childs, R, Barrett, AJ. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. Biol Blood Marrow Transplant, 12(12), 1261-9, 2006. PMCID:1849949

Savani, BN, Rezvani, K, Mielke, S, Montero, A, Kurlander, R, Carter, CS, Leitman, S, Read, EJ, Childs, R, Barrett, AJ. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood, 107(4), 1688-95, 2006. PMCID:1895415

Singh, AK, Karimpour, SE, Savani, BN, Guion, P, Hope, AJ, Mansueti, JR, Ning, H, Altemus, RM, Wu, CO, Barrett, AJ. Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant. Int J Radiat Oncol Biol Phys, 66(2), 520-7, 2006. PMCID:1849949

Montero, A, Savani, BN, Kurlander, R, Read, EJ, Leitman, SF, Childs, R, Solomon, SR, Barrett, AJ. Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning. Br J Haematol, 130(5), 733-9, 2005. PMCID:1895415

Savani, BN, Montero, A, Kurlander, R, Childs, R, Hensel, N, Barrett, AJ. Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation. Bone Marrow Transplant, 36(11), 1009-15, 2005. PMCID:1849949

Savani, BN, Montero, A, Wu, C, Nlonda, N, Read, E, Dunbar, C, Childs, R, Solomon, S, Barrett, AJ. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 11(3), 223-30, 2005. PMCID:1895160

Savani, BN, Srinivasan, R, Espinoza-Delgado, I, Dorrance, C, Takahashi, Y, Igarashi, T, Rezvani, K, Lundqvist, A, Barrett, AJ, Childs, RW. Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib. Lancet Oncol, 6(10), 809-12, 2005. PMCID:1849949

Solomon, SR, Mielke, S, Savani, BN, Montero, A, Wisch, L, Childs, R, Hensel, N, Schindler, J, Ghetie, V, Leitman, SF, Mai, T, Carter, CS, Kurlander, R, Read, EJ, Vitetta, ES, Barrett, AJ. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood, 106(3), 1123-9, 2005. PMCID:1895160

Solomon, SR, Savani, BN, Childs, R, Montero, A, Boss, C, Read, EJ, Leitman, SF, Barrett, AJ. Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome. Biol Blood Marrow Transplant, 11(8), 619-26, 2005. PMCID:1895415


Postdoctoral Position Available
N/A

Postdoctoral Position Details
N/A

Updated Date
03/20/2014



Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright 2008 Vanderbilt University School of Medicine
The office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket.